The use of ixel in the treatment of depression in patients with chronic schizophrenia

摘要: An open non-controlled 12-week study of 30 patients with chronic schizophrenia mild and moderate depression has been carried out. Ixel was administered in dosage 100-200 mg daily along the basic antipsychotic therapy (haloperidol, olanzapine, quetiapine, risperidone, paliperidone). Patient's state assessed Clinical Global impression scale (CGI), Hamilton (HAM-D-21) Positive Negative Syndromes (PANSS). Percentage responders on CGI 73.3%. A significant (p